Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 09-1995 | 06-1995 | 03-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 0 | 34,787 | 32,693 | 30,867 | 34,506 |
| TOTAL | $0 | $34,787 | $32,693 | $30,867 | $34,506 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 93,744 | 85,313 | 76,835 | 68,214 |
| Other Non-Current Assets | 0 | 45,970 | 4,888 | 2,845 | 2,947 |
| TOTAL | $N/A | $139,714 | $90,201 | $79,680 | $71,161 |
| Total Assets | $0 | $174,501 | $122,894 | $110,547 | $105,667 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 1,748 | 27 | 27 | 92 |
| Accounts payable and accrued liabilities | 0 | 9,776 | 3,867 | 4,910 | 4,230 |
| Accrued Expenses | 0 | 0 | 6,975 | 5,637 | 6,001 |
| TOTAL | $0 | $65,217 | $11,921 | $12,002 | $10,323 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 4,827 | 3,733 | 3,299 | 2,933 |
| TOTAL | $N/A | $59,951 | $53,479 | $45,690 | $48,229 |
| Total Liabilities | $0 | $125,168 | $65,400 | $57,692 | $58,552 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 364 | 361 | 360 | 357 |
| Other shareholders' equity | 0 | -341 | -446 | -1,123 | -1,976 |
| TOTAL | $0 | $96,127 | $94,795 | $93,605 | $91,110 |
| Total Liabilities And Equity | $0 | $221,295 | $160,195 | $151,297 | $149,662 |